Mobileye Global Inc. (MBLY) SEC Filings & Earnings Calls
EquiReason read 13 Mobileye Global Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-09-10 — Mobileye designated COO Yaacov Ohayon as principal operating officer and executive officer for Section 16 purposes. No change in duties or compensation. Routine organizational desi.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 5.5B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
10 Sep 20268-K · 5.02EVP Business Development & Strategy transitions to part-time role; VP of Business Development continues leading activities. No compensation changes disclosed.open
Risks flagged
Potential loss of strategic leadership continuity as EVP moves to part-time.
“Transition of EVP Business Development & Strategy to part-time role.”
12 Aug 20268-K · 5.02Director resignation by Patrick Bombach, Intel's Corporate VP, effective immediately; no disagreement with company operations.open
Risks flagged
Loss of Intel-affiliated board member may reduce strategic alignment with controlling shareholder.
“Resignation of Intel's Corporate VP from board; no operational disagreement stated.”
23 Jul 202610-QMobileye reported Q2 2026 revenue of $508M (flat YoY), net loss of $21M (improved from -$67M), and a $3.8B goodwill impairment in 1H 2026, with adjusted operating income up 46% YoY.earningsopen
Figures in the filing · each found in the filing text
| Revenue · 1H-2026 | $1.07B | +13% y/y |
| Net Income (Loss) · 1H-2026 | $-3.84B | |
| Operating Cash Flow · 1H-2026 | $210M | -35% y/y |
| Free Cash Flow · 1H-2026 | $159M | |
| Adjusted Operating Income · 1H-2026 | $250M | +52% y/y |
| Adjusted Net Income · 1H-2026 | $251M | +52% y/y |
Risks flagged
Goodwill Impairment Risk
“Goodwill impairment of $3,788 million recorded in Q1 2026, indicating a significant decline in the reporting unit's fair value.”
Gross Margin Compression
“Gross margin decreased from 50% to 46% in Q2 2026, driven by lower ASPs from Chinese OEMs and higher SuperVision mix.”
Geopolitical Risk (Israel)
“Approximately 2.4% of employees called to reserve duty; ongoing conflicts in the region could escalate.”
Supply Chain Risk
“AI industry demand for components increases competition for supply, leading to higher costs and potential shortages.”
Customer Concentration
“EyeQ SoC sales represented approximately 90% of revenue in Q2 2026.”
23 Jul 20268-K · 5.02, 7.01Founder and CEO Prof. Amnon Shashua informed board of intention to step down as CEO upon appointment of successor; board offered him role of Chairman.open
Risks flagged
CEO succession risk; founder departure may impact strategic direction and investor confidence.
“Founder and CEO stepping down after 27 years; no successor named yet.”
23 Jul 20268-K · 2.02Raised full-year 2026 revenue outlook midpoint by $20M to $1,970M-$2,020M; raised adjusted operating income midpoint by 88%; decreased operating loss midpoint by 4%. R&D incentive grant under new Israeli law boosts margins.open
Figures in the filing · each found in the filing text
| Revenue · Q2-2026 | $508M | 0% y/y |
| Adjusted Operating Income (Non-GAAP) · Q2-2026 | $155M | +46% y/y |
| Adjusted Diluted EPS (Non-GAAP) · Q2-2026 | $0.19 | +50% y/y |
| Operating cash flow · H1-2026 | $210M |
Guidance
Revenue midpoint raised by $20M to $1,970M-$2,020M; Adjusted Operating Income midpoint raised by 88%.
Raised full-year 2026 revenue and adjusted operating income guidance; R&D Law grant provides sustainable margin uplift.
24 Apr 2026DEF 14AProxy statement for 2026 annual meeting; no material event beyond routine governance matters.open
Risks flagged
Controlled company risk; Intel majority voting power
“As of April 22, 2026, Intel beneficially owns...approximately 96.9% of the voting power of our common stock.” · word for word
Related party transaction risk; CEO and CTO conflict in Mentee Robotics acquisition
“Prof. Shashua, our President and CEO, was the Chairman, Co-Founder and a significant shareholder of Mentee Robotics, and Prof. Shai Shalev-Shwartz, our Chief Technology Officer, was Co-Founder and a significant shareholder of Mentee Robotics.” · word for word
23 Apr 20268-K · 2.02Mobileye Q1 2026 revenue $558M (+27% YoY), beat expectations; raised FY2026 revenue midpoint by 2% to $1,935-2,015M; announced $250M buyback; goodwill impairment $3,788M non-cash.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $558M | +27% y/y |
| GAAP Gross Margin · Q1-2026 | 49.0% | |
| Adjusted Gross Margin · Q1-2026 | 66.0% | |
| GAAP Operating Income (Loss) · Q1-2026 | $-3.90B | +3230% y/y |
| Adjusted Operating Income · Q1-2026 | $95M | +61% y/y |
| Adjusted Diluted EPS · Q1-2026 | $0.12 | +50% y/y |
| Operating Cash Flow · Q1-2026 | $75M | |
| Goodwill Impairment · Q1-2026 | $3.79B |
Guidance
FY2026 revenue raised to $1,935-2,015M from prior midpoint $1,975M (2% increase); FY2026 Adjusted Operating Income raised to $185-235M from prior midpoint $210M (8% increase); FY2026 Operating Loss $(4,331)-(4,281)M; FY2026 Amortization $346M; FY2026 SBC $376M; FY2026 Goodwill impairment $3,788M; FY2026 Acquisition expenses $6M
Raised FY2026 revenue guidance by 2% and Adjusted Operating Income by 8% at midpoint, reflecting strong Q1 demand and operating leverage.
Risks flagged
Goodwill impairment risk due to market cap decline and macro uncertainty.
“due to a decline in our market capitalization since the most recent assessment date, as well as increased uncertainty in the macroeconomic and geopolitical environment, an interim impairment test was triggered.” · word for word
Customer concentration and demand normalization risk; part of growth attributed to safety stock normalization.
“A portion of this growth was related to the normalization of safety stock levels at customers, after some draw down that took place in the fourth quarter of 2025.” · word for word
23 Apr 202610-QQ1 2026 revenue up 27% YoY, gross margin up 200bps, adjusted operating margin up 400bps; partially offset by $3.788B goodwill impairment.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $558M | +27% y/y |
| Net Income (Loss) · Q1-2026 | $-3.82B | |
| Adjusted Net Income (Loss) · Q1-2026 | $96M | +52% y/y |
| Gross Margin · Q1-2026 | 49.0% | |
| Adjusted Gross Margin · Q1-2026 | 66.0% | |
| Adjusted Operating Margin · Q1-2026 | 17.0% | |
| EyeQ SoC Shipments · Q1-2026 | 10,800,000 | +27% y/y |
| Capital Expenditures · Q1-2026 | $30M | +114% y/y |
| Operating Cash Flow · Q1-2026 | $75M | -31% y/y |
| Free Cash Flow · Q1-2026 | $45M |
Risks flagged
Goodwill impairment risk
“Goodwill impairment expenses were $3,788 million in the three months ended March 28, 2026.” · word for word
Supply chain and AI component competition risk
“the AI industry has generated increased demand for components necessary for the production of our solutions...resulted in increased competition for and shortages of components...substantial increases in prices.” · word for word
Tariff and trade policy risk
“tariffs could lead to higher prices for finished automobiles, which would reduce demand for automobiles and thus the market for our products.” · word for word
Geopolitical risk in Israel
“approximately 7.0% of our employees have been called to reserve duty in the Israel Defense Forces.” · word for word
12 Feb 202610-KAnnual report filed; no revenue, continued losses, cash position disclosed.earningsopen
Figures in the filing · each found in the filing text
| Cash, cash equivalents and marketable securities · FY2025 | $729M | |
| Accumulated loss · FY2025 | $762M | |
| Net cash used in operating activities · FY2025 | $-148M |
Risks flagged
Pre-revenue clinical-stage company with no approved product
“We are a clinical-stage biopharmaceutical company and, since inception, we have incurred significant operating losses and expect to continue to do so for the foreseeable future.”
22 Jan 20268-K · 2.02FY2025 revenue +15% YoY to $1,894M; operating cash flow +51% to $602M; FY2026 guidance implies flat to 5% revenue growth; pipeline $24.5B (+42% vs 2022); Surround ADAS win with major US OEM; Mentee Robotics acquisition expands into humanoidearningsopen
Figures in the filing · each found in the filing text
| Revenue · FY2025 | $1.89B | +15% y/y |
| Revenue · Q4-2025 | $446M | -9% y/y |
| Gross Margin · Q4-2025 | 45.0% | |
| Adjusted Gross Margin · Q4-2025 | 67.0% | |
| Operating Cash Flow · FY2025 | $602M | +51% y/y |
| Cash and Cash Equivalents · FY2025 | $1.80B | |
| Diluted EPS (GAAP) · Q4-2025 | $-0.16 | |
| Adjusted Diluted EPS (Non-GAAP) · Q4-2025 | $0.06 | |
| Average System Price · Q4-2025 | $50.80 | +2% y/y |
| Pipeline · FY2025 | $24.50B |
Guidance
FY2026 revenue $1,900M-$1,980M (flat to 5% YoY growth); FY2026 Adjusted Operating Income $170M-$220M; Q1 2026 revenue growth ~19% YoY
FY2026 guidance implies flat to 5% revenue growth, with Q1 2026 expected to grow ~19% YoY, indicating a strong start to the year. Adjusted operating income guided to $170M-$220M. Management expresses confidence in strategic momentum and cash generation.
Risks flagged
Customer inventory destocking: Q4 revenue decline due to tighter-than-normal inventory at Tier 1 customers, indicating potential demand lumpiness.
“Revenue of $446 million decreased 9% as compared to the fourth quarter of 2024, primarily due to an 11% reduction in EyeQ SoC volumes. This was primarily related to a balancing of supply and demand that resulted in tighter-than-normal inventory levels at our Tier 1 customers exiting 2025.” · word for word
Gross margin pressure from product mix and amortization: GAAP gross margin down 389bps YoY; adjusted gross margin down 176bps.
“Gross Margin decreased by nearly 4 percentage points in the fourth quarter of 2025 as compared to the prior year period. The decrease was due to the impact of the cost attributable to amortization of intangible assets which was similar to the prior year but on a lower revenue base, in addition to a higher EyeQ-related cost per unit given the different mix of” · word for word
Mentee Robotics acquisition integration risk: $612M cash outlay and potential dilution from share-based compensation.
“The company ended the year with $1.8 billion in cash and cash equivalents, excluding the expected $612 million cash outlay for the Mentee Robotics acquisition at closing.” · word for word
7 Jan 20268-K · 2.02Mobileye estimated FY2025 revenue 'a bit short of $2B' at CES presentation; no precise results provided. Revenue pipeline of ~$8B highlighted. Formal Q4/FY results pending.earningsopen
Figures in the filing · each found in the filing text
| Revenue · FY2025 | $2.00B |
Risks flagged
Revenue slightly below $2B may indicate demand softness or execution challenges; precise results pending.
“revenue ... 'a bit short of $2 billion'”
Mobileye Global Inc. — questions
- What did Mobileye Global Inc. file recently?
- 13 SEC filings in the last 12 months. Latest: 8-K on 2026-09-10 — Mobileye designated COO Yaacov Ohayon as principal operating officer and executive officer for Section 16 purposes. No change in duties or compensation. Routine organizational designation.
Every figure on this page comes from Mobileye Global Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.